Luca Petricca

2.8k total citations
41 papers, 818 citations indexed

About

Luca Petricca is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Luca Petricca has authored 41 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 10 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Luca Petricca's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Luca Petricca is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Luca Petricca collaborates with scholars based in Italy, United States and United Kingdom. Luca Petricca's co-authors include Elisa Gremese, Gianfranco Ferraccioli, Barbara Tolusso, Stefano Alivernini, Anna Laura Fedele, Clara Di Mario, Maria Rita Gigante, Roberta Benvenuto, Laura Bui and Dario Bruno and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Luca Petricca

38 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Petricca Italy 16 294 167 139 104 91 41 818
Teresa Iwaniec Poland 18 350 1.2× 159 1.0× 79 0.6× 47 0.5× 257 2.8× 71 879
Simona Rednic Romania 19 477 1.6× 248 1.5× 102 0.7× 85 0.8× 78 0.9× 115 1.2k
C Tavernier France 18 276 0.9× 84 0.5× 58 0.4× 77 0.7× 81 0.9× 58 1.2k
Lucrezia Riente Italy 26 1.1k 3.6× 323 1.9× 109 0.8× 65 0.6× 206 2.3× 85 1.7k
Fabian Proft Germany 19 984 3.3× 471 2.8× 146 1.1× 51 0.5× 265 2.9× 131 1.4k
Chen Liu China 18 251 0.9× 369 2.2× 191 1.4× 20 0.2× 39 0.4× 88 1.0k
Koichiro Yano Japan 18 618 2.1× 69 0.4× 63 0.5× 33 0.3× 216 2.4× 94 1.2k
M. J. Elliott United Kingdom 18 260 0.9× 235 1.4× 129 0.9× 44 0.4× 110 1.2× 41 1.4k
Jean Denis Laredo France 18 187 0.6× 43 0.3× 93 0.7× 45 0.4× 56 0.6× 43 1.0k
Lê Thi Huong Dû France 12 327 1.1× 42 0.3× 78 0.6× 100 1.0× 46 0.5× 72 904

Countries citing papers authored by Luca Petricca

Since Specialization
Citations

This map shows the geographic impact of Luca Petricca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Petricca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Petricca more than expected).

Fields of papers citing papers by Luca Petricca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Petricca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Petricca. The network helps show where Luca Petricca may publish in the future.

Co-authorship network of co-authors of Luca Petricca

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Petricca. A scholar is included among the top collaborators of Luca Petricca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Petricca. Luca Petricca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petricca, Luca, et al.. (2025). Tracheal Adenoid Cystic Carcinoma: A Rare Salivary Gland-Type Tumor. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2795–A2795.
2.
Petricca, Luca, et al.. (2025). Improving Access for a Very Vulnerable Population: The First Centralized Lung Cancer Screening Program for the Department of Corrections. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5297–A5297.
3.
Bruno, Dario, Barbara Tolusso, Gianmarco Lugli, et al.. (2024). B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren’s Disease: A Pilot Monocentric Exploratory Study. International Journal of Molecular Sciences. 25(6). 3259–3259. 5 indexed citations
4.
Gremese, Elisa, et al.. (2023). Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. Journal of Clinical Medicine. 12(18). 6017–6017. 58 indexed citations
5.
Tolusso, Barbara, Luca Petricca, Clara Di Mario, et al.. (2022). Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig. Arthritis Research & Therapy. 24(1). 143–143. 6 indexed citations
6.
Bruno, Dario, Anna Laura Fedele, Barbara Tolusso, et al.. (2021). Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study. Frontiers in Medicine. 8. 613889–613889. 10 indexed citations
7.
Tosato, Matteo, Angelo Carfì, Cristina Pais, et al.. (2021). Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. Journal of the American Medical Directors Association. 22(9). 1840–1844. 51 indexed citations
8.
9.
Landi, Francesco, Angelo Carfì, Francesca Benvenuto, et al.. (2020). Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19. American Journal of Preventive Medicine. 60(1). 13–19. 30 indexed citations
10.
Natalello, G., Giacomo De Luca, Laura Gigante, et al.. (2020). Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvascular Research. 133. 104071–104071. 54 indexed citations
11.
Bruno, Dario, Maria Rita Gigante, Luca Petricca, et al.. (2020). THU0193 CLINICO-DEMOGRAPHIC, IMMUNOLOGIC AND SYNOVIAL HISTOLOGIC FEATURES INFLUENCING RESPONSE TO JAK-INHIBITORS IN RHEUMATOID ARTHRITIS: A MONOCENTRIC COHORT.. Annals of the Rheumatic Diseases. 79. 316–316. 1 indexed citations
12.
Petricca, Luca, Maria Rita Gigante, Annamaria Paglionico, et al.. (2020). Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies. Frontiers in Medicine. 7. 553075–553075. 9 indexed citations
13.
Alivernini, Stefano, Barbara Tolusso, Maria Rita Gigante, et al.. (2019). Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis. Scientific Reports. 9(1). 10420–10420. 25 indexed citations
14.
Alivernini, Stefano, Dario Bruno, Barbara Tolusso, et al.. (2019). Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 116–116. 30 indexed citations
15.
16.
Mario, Clara Di, Luca Petricca, Maria Rita Gigante, et al.. (2018). Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve. Endocrine. 63(2). 369–375. 24 indexed citations
17.
Tolusso, Barbara, Maria Rita Gigante, Stefano Alivernini, et al.. (2018). Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis. Frontiers in Medicine. 5. 207–207. 23 indexed citations
18.
20.
Frezza, Domenico, Barbara Tolusso, Vincenzo Giambra, et al.. (2012). Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 71(8). 1309–1315. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026